Wilmington, MA, United States of America

David Raymond Stover

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 105(Granted Patents)


Location History:

  • Wilmington, US (2001)
  • Wilmington, MA (US) (2003 - 2004)
  • Lexington, MA (US) (2012)
  • Sherman Oaks, CA (US) (2015)

Company Filing History:


Years Active: 2001-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: David Raymond Stover: Innovator in Biologic Compounds

Introduction

David Raymond Stover is a notable inventor based in Wilmington, Massachusetts, known for his substantial contributions to the field of biologic compounds. With a total of five patents to his name, Stover's innovative work primarily focuses on the development of treatments aimed at targeting various diseases, particularly those associated with critical cell receptors.

Latest Patents

Stover's latest patents highlight his significant advancements in medical technology. One of his prominent inventions is centered around biologic compounds directed against death receptor 5 (DR5). This invention encompasses amino acid sequences that target the TRAIL cell surface receptor 2, along with related compounds, proteins, polypeptides, and nucleotides. These agents are crucial for the diagnosis and treatment of diseases associated with DR5.

Another notable patent involves compositions and methods for antibodies of c-Met. This work features antibodies that effectively bind to the protein target c-Met, particularly epitopes within its extracellular domain. Stover's methodologies and the provided kits are aimed at treating unwanted cells associated with c-Met-related conditions, which include various cancers and inflammatory diseases.

Career Highlights

David Raymond Stover is currently employed at Novartis AG, a global healthcare company known for its research and innovation in pharmaceutical products. His role at Novartis allows him to merge his inventive spirit with cutting-edge science to develop impactful medical solutions.

Collaborations

Throughout his career, Stover has worked alongside esteemed colleagues, including Guido Bold and Jörg Frei. These collaborations have enabled him to enhance the scientific rigor and applicability of his inventions, fostering an environment of shared knowledge and innovation.

Conclusion

David Raymond Stover continues to be a prominent figure in the realm of biologic compounds, with his inventions paving the way for advancements in the treatment of severe medical conditions. His commitment to innovation at Novartis AG exemplifies the significant impact that dedicated inventors can have on public health and medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…